Exchange: NYSE·Updated 07:30 PM EST
ANRO logo

ANRO Alto Neuroscience Inc.

$25.37
$1.14
(4.30%)
Today
Closed $25.37
$0.00
(0.00%)
After Hours
Reported EarningsNov 10
Mkt Cap$1.02B
Vol522,541.00

About ANRO

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.
47

Neutral Sentiment

How do you feel about ANRO?

Advertisement|Remove ads.